Skip to content
OpenCapital
Get started

DexCom DXCM Q4 2025 Annual earnings

Reported February 12, 2026 · After market close

Revenue$1.3BBeat by $11.3MDiluted EPS$0.68Beat by $0.03
Revenue estimate$1.2B
EPS estimate$0.65

Next report

Jul 29, 2026 (In 2 weeks)
Revenue estimate$1.3B
EPS estimate$0.61

Financials

Q4 2025

Income statement

See full
Revenue$1.3B+13.1%
Gross profit$792.7M+20.9%
Operating income$323.0M+71.0%
Net income$267.3M+76.2%
EPS (diluted)$0.67+76.3%

Balance sheet

See full
Cash & equivalents$919.1M+51.3%
Total debt$155.5M+2.0%
Total equity$2.7B+30.6%
Total assets$6.3B-2.2%

Cash flow

See full
Operating cash flow$294.0M-2.5%
CapEx$101.9M-18.2%
Free cash flow$192.1M+8.7%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$25.89B-14.8%
Enterprise value$25.12B-16.0%
P/E31×-21.8×
P/S5.6×-2.0×

Profitability

See full
Gross margin60.1%-0.4pp
Operating margin19.6%+4.7pp
Net margin17.9%+3.7pp
FCF margin23.1%+7.5pp

Returns & leverage

See full
Return on equity34.5%+6.9pp
Debt / equity0.1×0.0×
Current ratio1.9×+0.4×

Versus estimates

Revenue

Q1 2026$1.2BBeat by $17.2M
Q4 2025$1.3BBeat by $11.3M
Q3 2025$1.2BBeat by $25.6MQ2 2025$1.2BBeat by $32.5MQ1 2025$1.0BBeat by $18.6MQ4 2024$1.1BBeat by $4.4M

Diluted EPS

Q1 2026$0.56Beat by $0.09
Q4 2025$0.68Beat by $0.03
Q3 2025$0.61Beat by $0.03Q2 2025$0.48Beat by $0.04Q1 2025$0.32Miss by $0.01Q4 2024$0.45Miss by $0.03

Ask the moment DexCom reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did DexCom report Q4 2025 earnings?
DexCom (DXCM) reported Q4 2025 earnings on February 12, 2026 after market close.
What were DexCom's Q4 2025 revenue and EPS?
DexCom reported revenue of $1.3B and diluted EPS of $0.68 for Q4 2025.
Did DexCom beat estimates in Q4 2025?
Revenue beat the consensus estimate of $1.2B by $11.3M. EPS beat the consensus estimate of $0.65 by $0.03.
How did DexCom's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 13.1% from $1.1B a year earlier and diluted EPS grew 51.1% from $0.45.
Where can I find DexCom's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001093557-26-000025) and the 10-K periodic report (0001093557-26-000027) directly on SEC EDGAR. The filing index links above go to sec.gov.